12:37 PM ET
8-K
Leadership Change
Merck & Co Leadership Change
Merck & Co., Inc. has elected Paul J. Diaz to its Board of Directors, effective November 1, 2026. Mr. Diaz, a managing partner at Cressey & Company and former CEO of Myriad Genetics and Kindred Healthcare, will serve on the Audit and Research Committees. His appointment increases the Merck board to 14 members ahead of his formal shareholder election in May 2027.
- Counterparty
- Paul J. Diaz